Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageStryker Corporation (Stryker or the Company) is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent orthopaedic surgeon and inventor of several medical products.
In the company’s own words · 10-K filed Feb 11, 2026 · SEC EDGAR
Business segments
Q2 2026 · $6.89BThe company’s own SEC segment disclosure.
- Trauma and Extremities$1.07B16%
- Endoscopy$1.00B15%
- Instruments$1.00B15%
- Ortho Tech$717.0M10%
- Knees$693.0M10%
- Neuro Cranial Instruments$681.0M10%
- Other (6)$1.72B25%
Stryker Corporation (SYK) reported revenue of $6.59B in Q2 2026 (quarter ended Jun 30, 2026), up 9.4% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $1.28B (19% of revenue). For the full year FY2025, revenue was $25.1B (+11% year on year) and net income $3.25B. Its largest product in Q2 2026 was Traumaand Extremities at $1.07B, 16% of the disclosed total, just ahead of Endoscopy at 15%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Devices
Ranks #10 of 29 by Smart Score